RNA methylation-related inhibitors: Biological basis and therapeutic potential for cancer therapy

Huanxiang Chen , Hongyang Liu , Chenxing Zhang , Nan Xiao , Yang Li , Xiangzhuan Zhao , Ruike Zhang , Huihui Gu , Qiaozhen Kang , Junhu Wan

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (4) : e1644

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (4) : e1644 DOI: 10.1002/ctm2.1644
REVIEW

RNA methylation-related inhibitors: Biological basis and therapeutic potential for cancer therapy

Author information +
History +
PDF

Abstract

• In this paper, several important types of RNA modifications and their related regulatory factors are systematically summarised.

• Several regulatory factors related to RNA modification types were associated with cancer progression, and their relationships with cancer cell migration, invasion, drug resistance and immune environment were summarised.

• In this paper, the inhibitors targeting different regulators that have been proposed in recent studies are summarised in detail, which is of great significance for the development of RNA modification regulators and cancer treatment in the future.

Keywords

cancer / drug resistance / inhibitor / RNA methylation

Cite this article

Download citation ▾
Huanxiang Chen,Hongyang Liu,Chenxing Zhang,Nan Xiao,Yang Li,Xiangzhuan Zhao,Ruike Zhang,Huihui Gu,Qiaozhen Kang,Junhu Wan. RNA methylation-related inhibitors: Biological basis and therapeutic potential for cancer therapy. Clinical and Translational Medicine, 2024, 14(4): e1644 DOI:10.1002/ctm2.1644

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

104

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/